First EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection

• Date:
  Wednesday, 05 November 2025 , 09:00 - 17:00 Amsterdam time (CET)
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands
  Live broadcast

Event summary

European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) are hosting the first EMA/HMA multi-stakeholder forum on EudraVigilance and signal Detection.

The Forum’s main objectives are to inform stakeholders on ongoing and forthcoming developments in international guidance, adverse drug reaction case processing, signal management and data analysis in EudraVigilance, and to foster stakeholder engagement and collaboration to further strengthen these areas.

Registration

Register now for virtual participation by 31 October 2025: First EMA/HMA Multi-Stakeholder Forum on EudraVigilance and Signal Detection.

Registration is not required to follow the event online via live broadcast.

Please note that this event will be recorded and made publicly available. By registering for this event, you are providing consent to EMA to process your data under Regulation (EU) 2018/1725. EMA’s data protection notice for the organisation of meetings and events and the Cisco Privacy Document, which explains how personal data is processed by the Agency and via the tool Webex.

Documents

Agenda – First EMA–HMA multi-stakeholder forum on EudraVigilance and signal detection

Live broadcast - 9:00 - 17:00 (CET)

You should see the live broadcast on pressing the 'play' icon in the video window, or a message stating that the event has not started yet.

To optimise video quality, once the video is playing we recommend clicking on the ‘Wheel’ symbol in the video window then selecting the Quality Option up to 1080p.

If the video window is blank, or if you experience other difficulties viewing the broadcast, please try connecting directly to the EMA's Vimeo Channel 1.

For technical information about the required network security settings, please see this Vimeo help page.

For further assistance, please consult the EMA Service desk.